BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 21457120)

  • 1. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
    Nair AB; Vaka SR; Murthy SN
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-ungual iontophoretic delivery of terbinafine.
    Nair AB; Vaka SR; Sammeta SM; Kim HD; Friden PM; Chakraborty B; Murthy SN
    J Pharm Sci; 2009 May; 98(5):1788-96. PubMed ID: 18781625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.
    Nair AB; Sammeta SM; Kim HD; Chakraborty B; Friden PM; Murthy SN
    Int J Pharm; 2009 Jun; 375(1-2):22-7. PubMed ID: 19481686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
    Nair AB; Sammeta SM; Vaka SR; Narasimha Murthy S
    J Pharm Pharmacol; 2009 Apr; 61(4):431-7. PubMed ID: 19298688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
    Nair AB; Kim HD; Chakraborty B; Singh J; Zaman M; Gupta A; Friden PM; Murthy SN
    J Pharm Sci; 2009 Nov; 98(11):4130-40. PubMed ID: 19340887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study.
    Amichai B; Nitzan B; Mosckovitz R; Shemer A
    Br J Dermatol; 2010 Jan; 162(1):46-50. PubMed ID: 19785609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery.
    Kushwaha A; Shivakumar HN; Murthy SN
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1678-82. PubMed ID: 26981643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iontophoresis across the proximal nail fold to target drugs to the nail matrix.
    Manda P; Sammeta SM; Repka MA; Murthy SN
    J Pharm Sci; 2012 Jul; 101(7):2392-7. PubMed ID: 22487899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.
    Amichai B; Mosckovitz R; Trau H; Sholto O; Ben-Yaakov S; Royz M; Barak D; Nitzan B; Shemer A
    Mycopathologia; 2010 May; 169(5):343-9. PubMed ID: 20012894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
    Vejnovic I; Huonder C; Betz G
    Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive study to evaluate the effect of constant low voltage iontophoresis on transungual delivery.
    Nair AB; Singh K; Shinu P; Harsha S; Al-Dhubiab BE
    Drug Dev Ind Pharm; 2013 May; 39(5):807-15. PubMed ID: 23057692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iontophoretic terbinafine delivery in onychomycosis: questionable nail growth.
    Oon HH; Tan HH
    Br J Dermatol; 2010 Mar; 162(3):699-700. PubMed ID: 20030642
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of polyethylene glycols on the trans-ungual delivery of terbinafine.
    Nair AB; Chakraborty B; Murthy SN
    Curr Drug Deliv; 2010 Dec; 7(5):407-14. PubMed ID: 20955143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment.
    Angamuthu M; Nanjappa SH; Raman V; Jo S; Cegu P; Murthy SN
    J Pharm Sci; 2014 Apr; 103(4):1178-83. PubMed ID: 24497012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
    Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
    Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
    Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies in drug transport vs. current in iontophoretic onychomycosis treatment.
    Barsness M; Davis SP; Etheredge R; Chang K; Kim H
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():289-94. PubMed ID: 19964736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
    Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
    J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.